FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Guilty Pleas in Fraudulent Supplement Sales Scheme

The Justice Department says five individuals and two companies are pleading guilty to fraudulently marketing two workout and weight loss dietary suppl...

Court Denies Summary Judgment in Teva Whistleblower Case

A New York federal judge says a whistleblower suit against a Teva speakers program for two drugs may proceed to trial.

Promoting Unapproved Drugs is OPDP Focus: Analysis

Healthcare communications consultant Mark Senak says the CDER Office of Prescription Drug Promotion is showing an enforcement focus on promotion of un...

Federal Register

Draft Guide on Pediatric Cancer Trial Eligibility

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Minimum Age for Pediatric Patients....

Biologics

10 Observations on Genetech FDA-483

FDA releases the FDA-483 with 10 observations from an inspection at the Genetech umbilical cord processing facility.

Human Drugs

Purdue on Fast Track for Potential Naloxone Competitor

FDA grants Purdue Pharma a fast track designation for nalmefene hydrochloride injection, an investigational opioid antagonist for the emergency treatm...

Federal Register

Draft Guide on Brain Metastases Trial Eligibility

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Brain Metastases.

Federal Register

Guide on Including Adolescents in Oncology Trials

Federal Register notice: FDA makes available a final guidance entitled Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clini...

Human Drugs

4 Observations in Immunomedics FDA-483

FDA issues an FDA-483 with four observations from an Immunomedics inspection.

Federal Register

Guide on Including Organ Dysfunction Patients in Trials

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or ...